References
- Broze G. J., Jr., Majerus P. W. Purification and properties of human coagulation factor VII. J Biol Chem 1986; 255: 1242–1247
- Roller F., Loeliger A., Duckert F. Experiments on a new clotting factor (factor VII). Acta Haematol 1951; 6: 1
- Alexander B., Goldstein R., Landwehr G., Cook C. D. Congenital SPCA deficiency. A hitherto unrecognized defect with hemorrhage rectified by serum and serum factors. J Clin Invest 1951; 30: 596–606
- Østerud B. Activation pathways of coagulation system in normal haemostasis. Scand J Haematol 1984; 32: 337–345
- Goodnight S. H., Feinstein D. J., Østerud B., Rapaport S. I. Factor VII-antibody-neutralizing material in hereditary and acquired factor VII deficiency. Blood 1971; 38: 1–8
- Mariani G., Mazzucconi M. G. Factor VII congenital deficiency. Clinical picture and classification of the variants. Haemostasis 1983; 13: 169–177
- Triplett D. A., Brandt J. T., McGann Batarel M. A., Schaeffer Dixon J. L., Fair D. S. Hereditary factor VII deficiency: Heterogeneity defined by combined functional and immunochemical analysis. Blood 1985; 66: 1284–1287
- Hall C. A., Rapaport S. I., Ames S. B. A clinical and family study of hereditary proconvertin (factor VII) deficiency. Am J Med 1964; 37: 172–181